SEC Form 4 · accession 0000899243-18-020579

MyoKardia Inc · MYOK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Business Officer

Period of report

Jul 23, 2018

Accepted (ET)

Jul 25, 2018 · 4:17 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001552451

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jul 23, 2018	M	7,500	$13.90	A	68,106	D
Common Stock^F2	Jul 23, 2018	S	4,399	$56.59	D	63,707	D
Common Stock^F3	Jul 23, 2018	S	3,101	$57.28	D	60,606	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$13.90	Jul 23, 2018	M	7,500	D	—	Jul 19, 2027	Common Stock	7,500	7,500	D

F1This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2Represents the weighted average sale price of the shares sold ranging from $56.00 to $56.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4The shares subject to this option vest and become exercisable in in two annual installments after July 20, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.

Exhibit 24.1 - Power of Attorney